Applied DNA Sciences

APDN62

Penny Stock

$1.21arrow_drop_down8.33%-$0.11

Penny Stock

APDN62

$1.21

arrow_drop_down8.33%-$0.11

Penny Stock

Performance History

Key Stats
Open	$1.41
Prev. Close	$1.37
EPS	-7.50
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$14.11M
PE Ratio	-

	LOW	HIGH
Day Range	1.32	1.42
52 Week Range	0.31	7.60

Ratios







EPS	-7.50

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Applied DNA Sciences (APDN)

Applied DNA Sciences Inc. (APDN) is a provider of molecular technologies for supply chain security, anti-counterfeiting, and anti-theft technology. The company's molecular taggant technology is used to mark and authenticate products in various industries, including textiles, automobiles, electronics, pharmaceuticals, and more. This technology allows for the verification of the authenticity and origin of products, as well as the tracing of supply chain disruptions or diversions. Through its proprietary SigNature DNA platform, Applied DNA Sciences offers a unique and secure way to protect brands and ensure product integrity.

The stock price history of Applied DNA Sciences Inc. (APDN) has seen fluctuations over the years. As of the most recent data available, the stock is trading at $5.76 per share. The company has a market capitalization of $153.97 million, indicating its size and value in the market. In terms of its performance relative to the industry, APDN has shown some positive signs. The company has a price-to-earnings growth (PEG) ratio of -0.04, which suggests that it may be undervalued compared to its industry peers. This could potentially make APDN an attractive investment opportunity for those looking for growth potential.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Dr. James A. Hayward Ph.D., Sc.D.
Headquarters: Stony Brook
Employees: 61
Exchange: NASDAQ

Keep an eye on Applied DNA Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

Is Applied DNA Sciences (APDN) a growth stock?

Applied DNA Sciences (APDN) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Applied DNA Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Applied DNA Sciences (APDN) stock price performance year to date (YTD)?

As of the latest data, Applied DNA Sciences (APDN) has a year-to-date price change of -90.24%. Over the past month, the stock has experienced a price change of -32.4%. Over the last three months, the change has been 165.93%. Over the past six months, the figure is -86.25%. Looking at a longer horizon, the five-year price change stands at -99.63%.

help

What is Applied DNA Sciences 's (APDN) price per share?

The current price per share for Applied DNA Sciences (APDN) is $1.21. The stock has seen a price change of -$0.11 recently, indicating a -8.33% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Applied DNA Sciences (APDN)?

For Applied DNA Sciences (APDN), the 52-week high is $7.6, which is 528.1% from the current price. The 52-week low is $0.31, the current price is 290.32% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Applied DNA Sciences (APDN) a profitable company?

Applied DNA Sciences (APDN) has a net income of -$10.02M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 41.39% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -419.64% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $13.37M, although specific revenue growth data is currently not available. The gross profit is $5.53M. Operating income is noted at -$10.95M. Furthermore, the EBITDA is -$13.98M.

help

What is the market capitalization of Applied DNA Sciences (APDN)?

Applied DNA Sciences (APDN) has a market capitalization of $13.6M. The average daily trading volume is 4.87M, indicating the stock's liquidity and investor engagement.